Search Results - "Lehrer, Douglas"
-
1
Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience
Published in The Journal of steroid biochemistry and molecular biology (01-05-2019)“…•Daily dosing with vitamin D ranged from 5000 IU/day to 50,000 IU/day.•No cases of hypercalcemia observed using these doses of vitamin D for up to 7 years.•The…”
Get full text
Journal Article -
2
Vitamin D, cod liver oil, sunshine, and phototherapy: Safe, effective and forgotten tools for treating and curing tuberculosis infections — A comprehensive review
Published in The Journal of steroid biochemistry and molecular biology (01-03-2018)“…•TB is a major public health problem, affecting one third of the world’s population.•Vitamin D deficiency is common in patients infected with TB throughout the…”
Get full text
Journal Article -
3
Psychiatric Comorbidities and Schizophrenia
Published in Schizophrenia bulletin (01-03-2009)“…Psychiatric comorbidities are common among patients with schizophrenia. Substance abuse comorbidity predominates. Anxiety and depressive symptoms are also very…”
Get full text
Journal Article -
4
Normal 24-hour urine calcium concentrations after long-term daily oral intake of vitamin D in doses ranging from 5000 to 50,000 international units in 14 adult hospitalized psychiatric patients
Published in The Journal of steroid biochemistry and molecular biology (01-07-2023)“…Many controversies exist regarding vitamin D3 supplementation. These include not only diseases that are responsive to vitamin D supplementation, but also the…”
Get full text
Journal Article -
5
Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia
Published in Psychiatry research (01-01-2018)“…WHODAS-2.0 is a suggested replacement to the GAF in DSM-5. This study's purpose was to assess their comparative correlation in adults with schizophrenia…”
Get full text
Journal Article -
6
Four-modality imaging of unmedicated subjects with schizophrenia: 18F-fluorodeoxyglucose and 18F-fallypride PET, diffusion tensor imaging, and MRI
Published in Psychiatry research. Neuroimaging (01-03-2022)“…•Combination of functional and structural imaging modalities provides better prediction of diagnosis of schizophrenia than either of the two…”
Get full text
Journal Article -
7
D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia
Published in Schizophrenia research (01-02-2018)“…Abstract Converging evidence indicates that the prefrontal cortex is critically involved in executive control and that executive dysfunction is implicated in…”
Get full text
Journal Article -
8
Reading abilities and dopamine D 2 /D 3 receptor availability: An inverted U-shaped association in subjects with schizophrenia
Published in Brain and language (01-12-2021)“…Reading impairments are prominent trait-like features of cognitive deficits in schizophrenia, predictive of overall cognitive functioning and presumably linked…”
Get full text
Journal Article -
9
Reading abilities and dopamine D2/D3 receptor availability: An inverted U-shaped association in subjects with schizophrenia
Published in Brain and language (01-12-2021)“…•Higher dopamine receptor density is associated with better reading ability.•Therefore, higher dopamine receptor density is cognitively…”
Get full text
Journal Article -
10
Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications
Published in Nutrients (29-04-2021)“…Vitamin D, sunshine and UVB phototherapy were first reported in the early 1900s to control psoriasis, cure rickets and cure tuberculosis (TB). Vitamin D also…”
Get full text
Journal Article -
11
Anosognosia in schizophrenia: hidden in plain sight
Published in Innovations in clinical neuroscience (01-05-2014)“…Poor insight is a cardinal symptom of schizophrenia that, while not universally and uniformly expressed in all patients, is among the most common of its…”
Get full text
Journal Article -
12
Relationship between white matter glucose metabolism and fractional anisotropy in healthy and schizophrenia subjects
Published in Psychiatry research. Neuroimaging (30-05-2020)“…Decreased fractional anisotropy and increased glucose utilization in the white matter have been reported in schizophrenia. These findings may be indicative of…”
Get full text
Journal Article -
13
Positive association between cerebral grey matter metabolism and dopamine D 2 /D 3 receptor availability in healthy and schizophrenia subjects: An 18 F-fluorodeoxyglucose and 18 F-fallypride positron emission tomography study
Published in The world journal of biological psychiatry (01-06-2020)“…Overlapping decreases in extrastriatal dopamine D /D -receptor availability and glucose metabolism have been reported in subjects with schizophrenia. It…”
Get full text
Journal Article -
14
Positive association between cerebral grey matter metabolism and dopamine D2/D3 receptor availability in healthy and schizophrenia subjects: An 18F-fluorodeoxyglucose and 18F-fallypride positron emission tomography study
Published in The world journal of biological psychiatry (01-06-2020)“…Objectives: Overlapping decreases in extrastriatal dopamine D 2 /D 3 -receptor availability and glucose metabolism have been reported in subjects with…”
Get full text
Journal Article -
15
Dopamine receptor density and white mater integrity: 18F-fallypride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects
Published in Brain imaging and behavior (01-06-2020)“…Dopaminergic dysfunction and changes in white matter integrity are among the most replicated findings in schizophrenia. A modulating role of dopamine in myelin…”
Get full text
Journal Article -
16
The genomic psychiatry cohort: Partners in discovery
Published in American journal of medical genetics. Part B, Neuropsychiatric genetics (01-06-2013)“…The Genomic Psychiatry Cohort (GPC) is a longitudinal resource designed to provide the necessary population‐based sample for large‐scale genomic studies,…”
Get full text
Journal Article -
17
Parental age effects on odor sensitivity in healthy subjects and schizophrenia patients
Published in American journal of medical genetics. Part B, Neuropsychiatric genetics (01-06-2016)“…A schizophrenia phenotype for paternal and maternal age effects on illness risk could benefit etiological research. As odor sensitivity is associated with…”
Get full text
Journal Article -
18
D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia
Published in Schizophrenia research (01-07-2006)“…Abnormalities in the dopaminergic system are implicated in schizophrenia. [F-18]fallypride is a highly selective, high affinity PET ligand well suited for…”
Get full text
Journal Article -
19
Paternal age effect: Replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis
Published in American journal of medical genetics. Part B, Neuropsychiatric genetics (01-06-2016)“…Advanced paternal age (APA) is a risk factor for schizophrenia (Sz) and bipolar disorder (BP). Putative mechanisms include heritable genetic factors, de novo…”
Get full text
Journal Article -
20
Measuring dopamine neuromodulation in the thalamus: Using [F-18]fallypride PET to study dopamine release during a spatial attention task
Published in NeuroImage (Orlando, Fla.) (15-05-2006)“…We used the highly selective D2/D3 dopamine PET radioligand [F-18]fallypride to demonstrate that cognitive task induced dopamine release can be measured in the…”
Get full text
Journal Article